Eylea 40 mg Injection
642.49$
503.30$
Eylea 40 mg injection is a vital treatment option belonging to the vascular endothelial growth factor (VEGF) inhibitors class, specifically designed to address a range of serious eye conditions. Administered directly into the eye, this innovative therapy effectively treats macular edema, a condition characterized by fluid accumulation in the macula, as well as diabetic retinopathy, which can lead to significant vision impairment for individuals with diabetes. Additionally, Eylea is utilized in managing wet age-related macular degeneration (AMD), a progressive disease that can severely affect central vision. By inhibiting VEGF, Eylea works to reduce abnormal blood vessel growth and fluid leakage, promoting healthier retinal function. Patients should be aware of potential side effects, including eye discomfort and increased intraocular pressure, and should consult with their healthcare provider for a comprehensive evaluation. With its proven efficacy, Eylea represents a critical advancement in preserving vision and improving quality of life for those affected by these debilitating eye disorders. Always follow your doctor's instructions and report any unusual symptoms following the injection.
الكمية
Active Pharmaceutical Ingredient
Uses
• Eylea 40 mg injection is primarily used to treat neovascular (wet) age-related macular degeneration (wet AMD). This condition can lead to significant vision loss and is characterized by abnormal blood vessel growth in the retina. By administering Eylea, patients may experience stabilization or improvement in their visual acuity. This makes it a crucial option for managing the progression of wet AMD.
• Another important use of Eylea 40 mg injection is in patients experiencing impaired vision due to macular edema secondary to retinal vein occlusion. Retinal vein occlusion can cause swelling and fluid accumulation in the macula, leading to blurred or distorted vision. Eylea helps reduce this edema, thereby improving visual function. It is often used when timely intervention is needed to prevent further vision deterioration.
• Eylea 40 mg injection is also effective for treating impaired vision resulting from diabetic macular edema (DME). DME occurs when diabetes leads to fluid leakage from retinal blood vessels, causing swelling in the macula. The administration of Eylea can help manage this condition by decreasing the fluid accumulation and improving visual outcomes. Regular treatment with Eylea may enhance the quality of life for patients with DME.
• Additionally, Eylea 40 mg injection is indicated for patients suffering from impaired vision due to myopic choroidal neovascularization (myopic CNV). This condition arises from abnormal blood vessel growth associated with high myopia, which can severely affect vision. Eylea works by targeting the underlying mechanisms of myopic CNV, helping to reduce its impact on vision. Patients receiving Eylea can often see improvements in their visual clarity and overall eye health.
Benefits
Eylea 40 mg Injection has shown several benefits for patients with certain eye conditions, particularly in the treatment of macular oedema, diabetic retinopathy, and wet age-related macular degeneration (AMD). Eylea 40 mg Injection may show some of the potential benefits. Eylea 40 mg Injection works by inhibiting vascular endothelial growth factor (VEGF), a protein that promotes abnormal blood vessel growth and leakage. By blocking VEGF, Eylea 40 mg Injection helps reduce the fluid accumulation and swelling in the macula, leading to a decrease in macular oedema. By reducing macular edema and preserving the integrity of the macula, Eylea 40 mg can potentially improve visual acuity (sharpness of vision) in patients. This can result in clearer and sharper central vision, allowing for better reading, driving, and performing daily activities that require detailed vision. In the case of wet AMD and diabetic retinopathy, Eylea 40 mg Injection inhibits the growth of abnormal blood vessels that can cause further damage to the retina. By preventing the proliferation of these vessels and reducing leakage, Eylea 40 mg can help slow down the progression of these conditions and minimize the risk of severe vision loss.
Side Effects
Like all medicines, Eylea 40 mg Injection can cause side effects, although not everybody gets them.
Most Common Side Effects
• Vision changes
• Bloody eye
• Eye pain
• Floating spot before eyes
• Blindness
• Spark of light
• Hoarseness of voice
Common Side Effects
• Joint pain
• chest tightness
• swelling
• Breathing difficulty
• Difficulty in swallowing
• Sudden loss of coordination
• Severe weakness or numbness in arms and legs
How To Use
Eylea 40 mg Injection is given as an injection into your eye. Your doctor will use a medicine to numb your eye before giving you the injection. You will receive this injection in a hospital or other clinic setting. Frequency and dosage will be decided as per your disease condition.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Eylea 40 mg Injection. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Eylea 40 mg. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Eylea 40 mg Injection should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Eylea 40 mg and report any unusual symptoms or changes in kidney function to their doctor. The dose of Eylea 40 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Eylea 40 mg. Eylea 40 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Eylea 40 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Eylea 40 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Eylea 40 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Eylea 40 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Eylea 40 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Eylea 40 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Eylea 40 mg Injection may cause blurred vision and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Eylea 40 mg.